来自Streblus asper的两个新的心脏糖化物
Yun-Xuan He1, Qin Ouyang1, Jin-Chang Huang2
1School of Pharmacy, Fudan University, Shanghai, P. R. China.
Chemistry & biodiversity
|December 31, 2024
概括
来自Streblus asper Lour的两个新的心脏糖化物. 被识别并测试了抗病毒和抗菌活性. 这些化合物显示出开发针对猪流行性腹病毒和细菌感染的新疗法的潜力.
科学领域:
- 自然产品 化学 化学
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 斯特雷布卢斯 (Streblus) 在洛尔 (Lour) 之后. 是生物活性化合物的植物来源.
- 心脏糖化物是一类具有多种生物活性的化合物.
- 对抗微生物和抗病毒性质的新型化合物的研究至关重要.
研究的目的:
- 从Streblus asper Lour.中分离和表征新的心脏糖化物.
- 评估这些化合物对猪流行性腹病毒 (PEDV) 的抑制作用.
- 评估分离的化合物对病原细菌的抗菌活性.
主要方法:
- 使用色谱技术分离化合物.
- 通过光谱分析 (NMR,MS) 和化学方法阐明结构.
- 在体外测试以确定抗病毒 (PEDV) 和抗菌活性.
主要成果:
- 两种新的心脏糖化物,斯特拉斯佩罗西德K (1) 和L (2),成功地被分离和鉴定出来.
- 还分离了五种已知的心脏葡萄糖类类似物 (3-7).
- 隔离的化合物表现出不同程度的PEDV抑制活性,并测试了细菌菌株.
结论:
- 这项研究成功地从Streblus asper Lour.中发现了新的心脏糖化物.
- 这些发现表明,这些化合物在抗击病毒和细菌感染方面具有潜在的治疗应用.
- 需要进一步的研究来探索这些天然产品的作用机制和优化这些天然产品的疗效.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
516
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
516
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K